OR WAIT null SECS
October 09, 2023
Cambrex has completed the expansion of its North Carolina facility, doubling its manufacturing capacity.
October 06, 2023
Biosynth has further strengthened its peptide division with the acquisition of Pepceuticals.
October 05, 2023
The Japanese biotech company plans to make good use of Orchard’s portfolio, furthering its goal of providing life-changing medical care through cell and gene therapy.
October 02, 2023
The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
September 29, 2023
Under the partnership, Sartorius will leverage SPARTA Biodiscovery’s technology to accelerate development of nanoparticles used for drug delivery.
September 28, 2023
Novo Nordisk’s obesity treatment has been so successful the company is now top of the ‘value pile’ in Europe.
September 26, 2023
Under a new pact, Genentech and PeptiDream will collaborate to discover and develop novel peptide-radioisotope drug conjugates.
September 21, 2023
The AstraZeneca rare disease group hopes to use these new gene therapy programs to bolster its work on genomic medicine.
September 20, 2023
Under the collaboration, Orionis will receive $47 million upfront to leverage its Allo-Glue platform to discover small-molecule monovalent glues.
Samsung Biologics and Bristol Myers Squibb have further expanded their strategic manufacturing agreement to include the large-scale manufacture of an antibody cancer drug substance.